24 Aug 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206233
22 Sep 2021
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-22-2021-1632297403.pdf
22 Apr 2021
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-21-2021-1619072775.pdf
05 Jan 2021
// PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/astrazeneca-divests-atacand-cheplapharm/
04 Jan 2021
// PRESS RELEASE
https://www.astrazeneca.com/media-centre/press-releases/2021/atacand-divestment-in-over-70-countries-completed.html#:~:text=AstraZeneca%20has%20completed%20the%20divestment,Cheplapharm%20Arzneimittel%20GmbH%20(Cheplapharm)
23 Jan 2019
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-23-2019-1548227584.pdf